[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637676":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":50,"collaborators":10,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":64,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Liver resection group",null,[12],"Procedure: liver resection",{"label":14,"type":10,"description":10,"interventionNames":15},"Non-surgery group",[16],"Drug: Systemic therapy combined with locoregional interventions",[18,23],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"PROCEDURE","liver resection","Patients undergo liver resection for tumor.",[9],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DRUG","Systemic therapy combined with locoregional interventions","Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions",[14],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Qi Cheng, M.D.","CONTACT","13871459541","chengqi@hust.edu.cn",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430030","China",{"type":43,"coordinates":44},"Point",[45,46],114.26667,30.58333,{"lat":46,"lon":45},[49],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Cheng Qi","Deputy Director of Hepatobiliary and Pancreatic Surgery Department","100637676",false,"NCT07587216","Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment","Inclusion Criteria:\n\n* Male or female aged ≥18 years at the time of signing the informed consent form\n* Clinically or histologically confirmed diagnosis of liver cancer\n* Recieving treatment and follow-up in Tongji Hospital\n\nExclusion Criteria:\n\n\\- Refuse participanting in this study","ALL","18 Years",{"count":62,"type":63},800,"ESTIMATED","2 Years","OBSERVATIONAL","This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin",[68],"Liver Cancer (Primary and Metastatic)","2026-06-02",{"date":71,"type":72},"2026-06-04","ACTUAL",{"date":74,"type":72},"2026-01-01",{"date":76,"type":63},"2029-12-31",{"name":5,"class":6},1]